INTERNATIONAL PATENT: IMMUSOFT CORPORATION FILES APPLICATION FOR "GLP-1 EXPRESSING MODIFIED B CELLS FOR THE TREATMENT OF METABOLIC DISEASE"

GENEVA, July 14 -- IMMUSOFT CORPORATION (454 N 34th StreetSeattle, Washington 98103) filed a patent application (PCT/US2025/010182) for "GLP-1 EXPRESSING MODIFIED B CELLS FOR THE TREATMENT OF METABOLIC DISEASE" on Jan 03, 2025. With publication no. WO/2025/147573, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAMPE, Christiane Susanne (7016 36th NESeattle, Washington 98115), AINSWORTH, Sean W. (4536 Orchard Trail Ct.Orchard Lake, Michigan 48324)

Abstract: The present disclosure relates to compositions and methods of ...